180 related articles for article (PubMed ID: 17429031)
1. Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.
Ueo H; Motohashi H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F391-7. PubMed ID: 17429031
[TBL] [Abstract][Full Text] [Related]
2. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
3. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.
Ueo H; Motohashi H; Katsura T; Inui K
Biochem Pharmacol; 2005 Oct; 70(7):1104-13. PubMed ID: 16098483
[TBL] [Abstract][Full Text] [Related]
4. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3.
Chioukh R; Noel-Hudson MS; Ribes S; Fournier N; Becquemont L; Verstuyft C
Drug Metab Dispos; 2014 Dec; 42(12):2041-8. PubMed ID: 25239859
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(5):450-5. PubMed ID: 20877132
[TBL] [Abstract][Full Text] [Related]
7. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
[TBL] [Abstract][Full Text] [Related]
9. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
[TBL] [Abstract][Full Text] [Related]
10. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction.
Uwai Y; Ozeki Y; Isaka T; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2011; 26(5):486-93. PubMed ID: 21697612
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Hamada Y; Ikemura K; Iwamoto T; Okuda M
Pharmacology; 2018; 101(3-4):176-183. PubMed ID: 29353278
[TBL] [Abstract][Full Text] [Related]
13. Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters.
Bakhiya N; Stephani M; Bahn A; Ugele B; Seidel A; Burckhardt G; Glatt H
J Am Soc Nephrol; 2006 May; 17(5):1414-21. PubMed ID: 16597690
[TBL] [Abstract][Full Text] [Related]
14. Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.
Watanabe H; Sakaguchi Y; Sugimoto R; Kaneko K; Iwata H; Kotani S; Nakajima M; Ishima Y; Otagiri M; Maruyama T
Clin Exp Nephrol; 2014 Oct; 18(5):814-20. PubMed ID: 24185403
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
16. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
17. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
18. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules.
Ekaratanawong S; Anzai N; Jutabha P; Miyazaki H; Noshiro R; Takeda M; Kanai Y; Sophasan S; Endou H
J Pharmacol Sci; 2004 Mar; 94(3):297-304. PubMed ID: 15037815
[TBL] [Abstract][Full Text] [Related]
19. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Motohashi H; Uwai Y; Hiramoto K; Okuda M; Inui K
Eur J Pharmacol; 2004 Oct; 503(1-3):25-30. PubMed ID: 15496291
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]